174 related articles for article (PubMed ID: 25344214)
1. Identification of prohibitin 1 as a potential prognostic biomarker in human pancreatic carcinoma using modified aqueous two-phase partition system combined with 2D-MALDI-TOF-TOF-MS/MS.
Zhong N; Cui Y; Zhou X; Li T; Han J
Tumour Biol; 2015 Feb; 36(2):1221-31. PubMed ID: 25344214
[TBL] [Abstract][Full Text] [Related]
2. Prohibitin is an important biomarker for nasopharyngeal carcinoma progression and prognosis.
Liao Q; Guo X; Li X; Xiong W; Li X; Yang J; Chen P; Zhang W; Yu H; Tang H; Deng M; Liang F; Wu M; Luo Z; Wang R; Zeng X; Zeng Z; Li G
Eur J Cancer Prev; 2013 Jan; 22(1):68-76. PubMed ID: 22728421
[TBL] [Abstract][Full Text] [Related]
3. Proteomic Analysis of Metastasis-Specific Biomarkers in Pancreatic Cancer: Galectin-1 Plays an Important Metastatic Role in Pancreatic Cancer.
Tung CL; Lin MW; Hu RY; Chien YC; Liao EC; Lin LH; Chung TW; Wei YS; Tsai YT; Chen HY; Chou HC; Kuo WH; Ko ML; Chang SJ; Lee YR; Chan HL
J Pharm Biomed Anal; 2020 Jul; 186():113300. PubMed ID: 32413824
[TBL] [Abstract][Full Text] [Related]
4. [Validation of candidate immunogenic membrane antigens of human pancreatic cancer screened by proteomics].
Wang WB; Zhao YP; Liao Q; Zhang TP; Xu L; Wu YD
Zhonghua Wai Ke Za Zhi; 2012 Mar; 50(3):260-3. PubMed ID: 22800753
[TBL] [Abstract][Full Text] [Related]
5. Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples.
Freed GL; Cazares LH; Fichandler CE; Fuller TW; Sawyer CA; Stack BC; Schraff S; Semmes OJ; Wadsworth JT; Drake RR
Laryngoscope; 2008 Jan; 118(1):61-8. PubMed ID: 18043497
[TBL] [Abstract][Full Text] [Related]
6. A new strategy to screen molecular imaging probe uptake in cell culture without radiolabeling using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Cheng Z; Winant RC; Gambhir SS
J Nucl Med; 2005 May; 46(5):878-86. PubMed ID: 15872363
[TBL] [Abstract][Full Text] [Related]
7. Routine identification of microorganisms by matrix-assisted laser desorption ionization time-of-flight mass spectrometry: Success rate, economic analysis, and clinical outcome.
Ge MC; Kuo AJ; Liu KL; Wen YH; Chia JH; Chang PY; Lee MH; Wu TL; Chang SC; Lu JJ
J Microbiol Immunol Infect; 2017 Oct; 50(5):662-668. PubMed ID: 27426930
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
[TBL] [Abstract][Full Text] [Related]
9. Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.
Chung JC; Oh MJ; Choi SH; Bae CD
ANZ J Surg; 2008 Apr; 78(4):245-51. PubMed ID: 18366394
[TBL] [Abstract][Full Text] [Related]
10. Performance of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) in diagnosis of ovarian cancer: a systematic review and meta-analysis.
Li K; Pei Y; Wu Y; Guo Y; Cui W
J Ovarian Res; 2020 Jan; 13(1):6. PubMed ID: 31924227
[TBL] [Abstract][Full Text] [Related]
11. Profiling the potential tumor markers of pancreatic ductal adenocarcinoma using 2D-DIGE and MALDI-TOF-MS: up-regulation of Complement C3 and alpha-2-HS-glycoprotein.
Chen J; Wu W; Chen L; Zhou H; Yang R; Hu L; Zhao Y
Pancreatology; 2013; 13(3):290-7. PubMed ID: 23719603
[TBL] [Abstract][Full Text] [Related]
12. Comparison of biomarker based Matrix Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS) and conventional methods in the identification of clinically relevant bacteria and yeast.
Kassim A; Pflüger V; Premji Z; Daubenberger C; Revathi G
BMC Microbiol; 2017 May; 17(1):128. PubMed ID: 28545528
[TBL] [Abstract][Full Text] [Related]
13. Use of ribosomal proteins as biomarkers for identification of Flavobacterium psychrophilum by MALDI-TOF mass spectrometry.
Fernández-Álvarez C; Torres-Corral Y; Santos Y
J Proteomics; 2018 Jan; 170():59-69. PubMed ID: 28939340
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of glycation and glycation sites of lysozyme by matrix-assisted laser desorption/ionization time of flight/time-of-flight mass spectrometry and Liquid chromatography-electrospray ionization tandem mass spectrometry.
Ruan ED; Wang H; Ruan Y; Juáreza M
Eur J Mass Spectrom (Chichester); 2014; 20(4):327-36. PubMed ID: 25420345
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of matrix-assisted laser desorption ionization-time of flight mass spectrometry combined with antimicrobial stewardship interventions in patients with bloodstream infections in a Japanese tertiary hospital.
Niwa T; Yonetamari J; Hayama N; Fujibayashi A; Ito-Takeichi S; Suzuki K; Ohta H; Niwa A; Tsuchiya M; Yamamoto M; Hatakeyama D; Hayashi H; Obara M; Sugiyama T; Baba H; Suzuki A; Murakami N
Int J Clin Pract; 2019 May; 73(5):e13332. PubMed ID: 30810264
[TBL] [Abstract][Full Text] [Related]
16. [A preliminary study on screening for Porphyromonas gingivalis outer membrane protein antigen with two-dimensional liquid phase fractionation and matrix-assisted laser desorption ionization time-of-flight/time-of-flight mass spectrometry].
Li A; Si WH; Wang SC; Shi JF; Rao GZ; Gou JZ
Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 Dec; 45(12):749-53. PubMed ID: 21211243
[TBL] [Abstract][Full Text] [Related]
17. Identification of prohibitin as a potential biomarker for colorectal carcinoma based on proteomics technology.
Chen D; Chen F; Lu X; Yang X; Xu Z; Pan J; Huang Y; Lin H; Chi P
Int J Oncol; 2010 Aug; 37(2):355-65. PubMed ID: 20596663
[TBL] [Abstract][Full Text] [Related]
18. Early identification of microorganisms in blood culture prior to the detection of a positive signal in the BACTEC FX system using matrix-assisted laser desorption/ionization-time of flight mass spectrometry.
Wang MC; Lin WH; Yan JJ; Fang HY; Kuo TH; Tseng CC; Wu JJ
J Microbiol Immunol Infect; 2015 Aug; 48(4):419-24. PubMed ID: 24388584
[TBL] [Abstract][Full Text] [Related]
19. Identification of SCARA5 as a Potential Biomarker for Oral Squamous Cell Carcinoma using MALDI-TOF-MS Analysis.
Liu Y; Tan YR; Sun WW; Ju WT; Fu Y; Wang LZ; Li J; Zhang CP; Zhang ZY; Zhong LP
Proteomics Clin Appl; 2018 Sep; 12(5):e1700180. PubMed ID: 29461673
[TBL] [Abstract][Full Text] [Related]
20. Current Status of Matrix-Assisted Laser Desorption/Ionization-Time-of-Flight Mass Spectrometry (MALDI-TOF MS) in Clinical Diagnostic Microbiology.
Tsuchida S; Umemura H; Nakayama T
Molecules; 2020 Oct; 25(20):. PubMed ID: 33080897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
